Bicara Therapeutics reported cash from operations of -$44.21M and free cash flow of -$44.27M for the quarter ended Jun 2026, down 72.7% year over year. This cash flow statement covers 12 quarters of results from Sep 2023 through Jun 2026, standardized by Business Quant from the company’s SEC filings.
| Cash Flow Statement | Sep2023 | Dec2023 | Mar2024 | Jun2024 | Sep2024 | Dec2024 | Mar2025 | Jun2025 | Sep2025 | Dec2025 | Mar2026 | Jun2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | ||||||||||||
| Net Income | -22.84M | -12.44M | -12.51M | -17.05M | -17.48M | -20.96M | -36.85M | -27.39M | -36.33M | -37.39M | -56.21M | -55.44M |
| Share-based Compensation | 0.77M | 1.15M | 1.04M | 2.03M | 3.18M | 3.45M | 3.49M | 3.61M | 4.45M | 5.86M | 8.24M | |
| Cash from Operations | -8.04M | -14.59M | -12.91M | -17.22M | -30.03M | -28.11M | -25.59M | -29.25M | -23.89M | -37.51M | -44.21M | |
| Depreciation, Depletion & Amortization | ||||||||||||
| Amortizatization of Intangibles | 0.07M | 0.07M | 0.07M | -0.20M | 0.14M | 0.21M | 0.25M | -0.90M | -0.34M | -0.24M | ||
| Change in Working Capital | ||||||||||||
| Change in Accured Expenses | -1.16M | -3.42M | 4.63M | -3.59M | 9.00M | 3.28M | -5.99M | 4.05M | 6.33M | 11.72M | 4.96M | |
| Other Working Capital Changes | 0.06M | 0.23M | -0.06M | 0.11M | 16.57M | -4.12M | -0.63M | 0.30M | -0.84M | -2.09M | 1.40M | |
| Investing Activities | ||||||||||||
| Capital Expenditures | 0.44M | 0.00M | 0.02M | 0.01M | 0.04M | 0.04M | 0.24M | 0.06M | 0.06M | |||
| Sales of Property, Plant and Equipment | 0.06M | |||||||||||
| Change in Acquisitions & Divestments | 101.00M | 60.00M | ||||||||||
| Cash from Investing Activities | -0.44M | 0.06M | -0.02M | -0.01M | -0.04M | -236.12M | -82.33M | 100.94M | -184.99M | |||
| Financing Activities | ||||||||||||
| Other financing activities | 0.14M | 1.33M | 0.06M | 0.08M | 0.46M | 0.14M | 0.44M | 1.73M | 1.58M | 2.33M | ||
| Change in Capital Stock | ||||||||||||
| Net Equity Issued and Repurchased | 272.30M | -1.05M | 29.50M | 161.76M | ||||||||
| Misc. | ||||||||||||
| Cash from Financing Activities | 194.70M | 0.14M | 0.73M | 334.13M | -0.97M | 0.46M | 0.14M | 0.44M | 31.23M | 163.34M | 2.33M | |
| Change in Cash | 186.23M | -14.39M | -12.19M | 316.90M | -31.05M | -27.65M | -25.46M | -264.93M | -74.99M | 226.78M | -226.86M | |
| Free Cash Flow | -8.47M | -14.59M | -12.93M | -17.23M | -30.07M | -28.11M | -25.59M | -29.29M | -24.12M | -37.57M | -44.27M | |
| Net Cash Flow | 186.23M | -14.39M | -12.19M | 316.90M | -31.05M | -27.65M | -25.46M | -264.93M | -74.99M | 226.78M | -226.86M |